Home
Conditions
Pancreatic Neoplasms

Clinical trial condition

Pancreatic Neoplasms

Explore clinical trials studying Pancreatic Neoplasms. Study availability and eligibility vary by location and protocol.

2,460 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Pancreatic Neoplasms trial results

Completed

Erlotinib Combined With Gemcitabine in Treating Patients With Newly Diagnosed Locally Advanced or Metastatic Pancreatic Cancer or Other Solid Tumors

NCT00033241

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations: Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States

Cancer Therapy and Research Center San Antonio, Texas, United States

View Trial Details

Completed

OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.

NCT00040183

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Arizona Clinical Research Center Tucson, Arizona, United States

Highlands Oncology Group Springdale, Arkansas, United States

Alta Bates Comprehensive Cancer Center Berkeley, California, United States

Loma Linda University Cancer Institute Loma Linda, California, United States

View all 140 locations

View Trial Details

Completed

Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer

NCT00810719

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States

University of California Davis Cancer Center Sacramento, California, United States

View Trial Details

Completed

Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery

NCT01234935

Conditions: Acinar Cell Adenocarcinoma of the Pancreas, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations: Central Hematology Oncology Medical Group, Inc. Alhambra, California, United States

TORI FULLERTON (St. Jude Heritage Healthcare Virginia K. Crosson Cancer Center) Fullerton, California, United States

Pacific Shores Medical Group Long Beach, California, United States

UCLA medical center Los Angeles, California, United States

View all 17 locations

View Trial Details

Completed

Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB

NCT01589328

Conditions: Behavior, Behavioral Symptoms, Biliary Tract Cancer, +17 more
Locations: National Cancer Center Goyang, 410-769, Gyeonggi-do, South Korea

View Trial Details

Completed

Phase II Gemcitabine + Fractionated Stereotactic Radiotherapy for Unresectable Pancreatic Adenocarcinoma

NCT01146054

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Stanford University School of Medicine Stanford, California, United States

Johns Hopkins Hospital Baltimore, Maryland, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

NCT00622674

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +50 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Capecitabine and Docetaxel in Treating Patients With Recurrent or Progressive Metastatic Pancreatic Cancer

NCT00290693

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations: Mayo Clinic - Jacksonville Jacksonville, Florida, United States

University of Miami Miami, Florida, United States

Mount Sinai Comprehensive Cancer Center at Mount Sinai Medical Center Miami Beach, Florida, United States

View Trial Details

Completed

Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma

NCT00201838

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +9 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors

NCT00703638

Conditions: Adenoma, Breast Cancer, Breast Diseases, +43 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Pancreatic Neoplasms

Pancreatic Neoplasms trial results

Related conditions